Main Banner Desktop
similispharma

SIMILIS PHARMA LIMITED

Unverified company Unverified company
map-marker

Since 2025

map-marker

United Kingdom

About Us

Similis Pharma Limited is a UK-based pharmaceutical wholesaler and exporter, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). Headquartered in London, we specialize in the supply of high-quality pharmaceuticals and aesthetic products to global markets. We are a trusted exporter of weight management medications, including Ozempic, Wegovy, and Mounjaro, ensuring access to innovative solutions for diabetes and weight loss management. Additionally, we provide a comprehensive range of aesthetic and beauty injectables, such as Botox, Azzalure, and Bacutiol, catering to the needs of medical professionals and aesthetic clinics worldwide. With a commitment to regulatory compliance, quality assurance, and global distribution excellence, Similis Pharma Limited ensures the safe and efficient supply of pharmaceuticals to meet the evolving demands of healthcare providers and consumers. For inquiries or partnership opportunities, contact us today to explore how we can support your pharmaceutical and aesthetic product needs.

Main Markets

  • Africa
  • Asia
  • Eastern Europe
  • Middle East
  • North America
  • Oceania
  • South America
  • Southwest Asia
  • Western Europe

More about
SIMILIS PHARMA LIMITED

icone de usuario

0-10

Employees

sales icon

200K - 500K

Sales volume (USD)

icone de exportar

70%

% Export sales

2024

Year

Established


Business type
  • Importer / Trading Company
  • Distributor / Wholesaler

Keywords
  • Ozempic
  • Wegovy
  • and Mounjaro
  • Botox
  • Anti-cancer products

Contact and location
  • icone de usuario GHANSHYAM ********
  • icone de telefone +44 7********
  • map-marker London / Stanmore | United Kingdom

Make your Request!

Make your Request!

Start conversation
logo-Whatsapp icon-checked-none

Hello 👋!
Can we help you?

Fill in your name and phone number 😁

Start conversation Start conversation